Article Text

PDF
Efficacy of avian pneumovirus vaccines against an avian pneumovirus/Escherichia coli 02:K1 dual infection in turkeys
  1. S. Van de Zande, DVM,PhD1,
  2. H. Nauwynck, DVM, PhD1 and
  3. M. Pensaert, DVM, PhD,Drhc1
  1. 1 Laboratory of Virology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium

Abstract

The clinical, pathological and microbiological outcome of a challenge with avian pneumovirus (APv) and Escherichia coli 02:K1 was evaluated in turkeys vaccinated with an attenuated APV vaccine and with or without maternally derived antibodies. Two groups of two-week-old poults, one with and one without maternally derived antibodies against APV, were vaccinated oculonasally with attenuated APV subtype A or B. A third group remained unvaccinated. Eleven weeks later, the turkeys were inoculated intranasally with either virulent APV subtype A, or E coli 02:K1, or with both agents three days apart. After the dual infection, birds vaccinated with attenuated subtype A or B, and with or without maternally derived antibodies, had lower mean clinical scores than the unvaccinated birds. In the vaccinated birds, virus replication was significantly reduced and no bacteria were isolated, except from the birds vaccinated with attenuated subtype B. In the unvaccinated turkeys, large numbers of E coli 02:K1 were isolated from the turbinates of the dually infected birds between one-and-a-half and seven days after they were inoculated.

    Statistics from Altmetric.com

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.